HOME

ABOUT BF

R&D

Industrial Production Mechanism Study Clinical Research

NERVONIC ACID

NEWS

CONTACT US

Baofeng Biology signs a strategic agreement with the Plateau Medical Research Center

Author:bfuers

Add_Time:2020-7-31 11:05:13

views

On June 30, 2020, Baofeng Biotechnology (Beijing) Co., Ltd. signed a strategic agreement with the Plateau Medical Research Center of China Medical University. In the future, the two sides of the agreement will jointly devote themselves to the study of the biological process and molecular mechanism of nerve repair of nervonic acid and cerebral hypoxia, especially the clinical study of neuroacid attenuating hypoxic brain injury at high altitude, and establish a long-term strategic cooperative relationship.


In high altitude areas, due to natural environmental factors, the incidence of high altitude diseases is relatively high. The Plateau Medical Research Center of China Medical University

focuses on the field of pediatrics, such as neonatal asphyxia, premature infants related diseases and infant pulmonary hypertension, and so on. The study of these diseases is of great significance for improving the average life expectancy and promoting the health and well-being of the people in the plateau areas.


微信图片_20200731110935.png



Professor Li Jiujun, currently in charge of the Plateau Medical Research Center of China Medical University, led the strategic cooperation with Baofeng Biotechnology (Beijing) Co., Ltd. Li Jiujun studied in Guangzhou Children's Hospital and Zhejiang University Children's Hospital and studied in PICU,NICU of shands Hospital of University of Florida for half a year. Once served as the head of the expert group of the Ministry of Health to Fuyang, Anhui Province for the treatment of hand, foot and mouth disease, and the captain of Liaoning assistance medical team for hand, foot and mouth disease in Fuyang, Anhui Province. Be good at pediatric respiratory diseases, such as all kinds of poisoning, congenital heart disease complicated with severe pneumonia, asthma, chronic cough, intracranial infection, mechanical ventilation, blood purification in the treatment of poisoning, acute renal failure, Guillain and so on.


Baofeng Biotechnology (Beijing) Co., Ltd. is mainly engaged in the R & D, production and sales of botanical nervonic acid and related brain health products. Baofeng Biotechnology (Beijing) Co., Ltd. is a global authoritative quasi-unicorn company that provides overall solutions to brain health. is a national high-tech enterprise and Zhongguancun high-tech enterprise. Baofeng Biology cooperates deeply with many famous research institutions at home and abroad, such as the Chinese Academy of Sciences, the National Health Commission, China Medical University, Beijing Tiantan Hospital, Xuanwu Hospital, PLA General Hospital, the first affiliated Hospital of Tsinghua University, and many famous research institutions at home and abroad, such as American Medical Nutrition and Health products Research and Development Institute, Japan International Institute of Agricultural Science and Technology, etc., to carry out the research and development of nervonic acid brain health products, including functional food for neurological diseases. The research and development of first-class new drugs, as well as the development of third-class medical devices such as brain disease detection kits, have applied for a number of patents and copyrights.


The strategic cooperation with the Plateau Medical Research Center of China Medical University provides strong academic and clinical support and guarantee for Baofeng biology's research and product research in the field of nervous system. In the foreseeable future, Baofeng Biology will continue to work with the top medical institutions represented by the Plateau Medical Research Center of China Medical University to develop the world's leading new technology for neurological diseases. provide efficient neurological disease diagnosis and intervention products worldwide. At the same time, Baofeng Bio also actively advocates the health system reform proposed by the government, participates in the construction of a national demonstration project of 5G + intelligent medical care, implements the strategic goal of healthy China 2030, and strives to move forward.